Lobbying client

VIRTUS PHARMACEUTICALS LLC

Pharmaceutical Development

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
18
Filed by
2
Reported in-house
—
Reported by firms
$210,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2016 to 2019

Filings

18 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2019
MEHLMAN CONSULTING, INC. — reported
4th Quarter - Report (No Activity)
4th Quarter 2018
MEHLMAN CONSULTING, INC. — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2018
MEHLMAN CONSULTING, INC. — reported
2nd Quarter - Report
2nd Quarter 2018
MEHLMAN CONSULTING, INC. $30,000 reported
1st Quarter - Report
1st Quarter 2018
MEHLMAN CONSULTING, INC. $30,000 reported
4th Quarter - Report
4th Quarter 2017
MEHLMAN CONSULTING, INC. $20,000 reported
3rd Quarter - Report
3rd Quarter 2017
MEHLMAN CONSULTING, INC. $40,000 reported
2nd Quarter - Report
2nd Quarter 2017
MEHLMAN CONSULTING, INC. $10,000 reported
Registration - Amendment
2nd Quarter 2017
MEHLMAN CONSULTING, INC. — reported
1st Quarter - Termination (No Activity)
1st Quarter 2017
MEHLMAN CONSULTING, INC. — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
MEHLMAN CONSULTING, INC. 11 $170,000
RED+BLUE STRATEGIES 1 $40,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Pharmacy PHA 11
Health Issues HCR 10
Budget/Appropriations BUD 9

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.